Glintborg, B., Sørensen, J., & Hetland, M. L. (2018). Does a mandatory non-medical switch from originator to biosimilar infliximab lead to increased use of outpatient healthcare resources? A register-based study in patients with inflammatory arthritis. RMD Open.
Citação norma ChicagoGlintborg, Bente, Jan Sørensen, and Merete Lund Hetland. "Does a Mandatory Non-medical Switch From Originator to Biosimilar Infliximab Lead to Increased Use of Outpatient Healthcare Resources? A Register-based Study in Patients With Inflammatory Arthritis." RMD Open 2018.
Citação norma MLAGlintborg, Bente, Jan Sørensen, and Merete Lund Hetland. "Does a Mandatory Non-medical Switch From Originator to Biosimilar Infliximab Lead to Increased Use of Outpatient Healthcare Resources? A Register-based Study in Patients With Inflammatory Arthritis." RMD Open 2018.